Literature DB >> 15640548

The pathology of preclinical medullary thyroid carcinoma.

Michael Ashworth1.   

Abstract

Medullary carcinoma of the thyroid (MTC) occurs sporadically, or in familial forms in familial medullary thyroid carcinoma and multiple endocrine neoplasia types 2A and 2B. In the familial forms it is associated with well-characterized, germline mutations in the RET protooncogene. The mutation sites differ in MEN2A and MEN2B, and MTC develops at an earlier age and is more aggressive in MEN2B. Screening of relatives of affected individuals for such mutations can identify those at risk of developing MTC and total thyroidectomy can be carried out in the first decade of life before the development of clinical disease. Analysis of such removed thyroid glands shows abnormalities of the parafollicular C-cells in almost all cases. The abnormalities range from C-cell hyperplasia, either diffuse or nodular, to microcarcinoma and occasionally frank MTC. The abnormalities are bilateral and affect the upper two thirds of the thyroid lobes. Microcarcinomas may be visible with the naked eye, but often they are identified only on microscopy. Histopathological examination of the entire gland is essential.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15640548     DOI: 10.1385/ep:15:3:227

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  23 in total

1.  C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors.

Authors:  J Albores-Saavedra; H Monforte; M Nadji; A R Morales
Journal:  Hum Pathol       Date:  1988-07       Impact factor: 3.466

Review 2.  Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease.

Authors:  C Eng
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

3.  Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.

Authors:  Gabriela E Sanso; Horacio M Domene; RudazMariaC Garcia; Eduardo Pusiol; MondinoAnaK de; Maria Roque; Alejandro Ring; Hector Perinetti; Boris Elsner; Sonia Iorcansky; Marta Barontini
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

4.  C-cell hyperplasia preceding medullary thyroid carcinoma.

Authors:  H J Wolfe; K E Melvin; S J Cervi-Skinner; A A Saadi; J F Juliar; C E Jackson; A H Tashjian
Journal:  N Engl J Med       Date:  1973-08-30       Impact factor: 91.245

5.  Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.

Authors:  K Kaserer; C Scheuba; N Neuhold; A Weinhäusel; O A Haas; H Vierhapper; B Niederle
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

6.  C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin.

Authors:  L Scopsi; S Di Palma; C Ferrari; J J Holst; J F Rehfeld; F Rilke
Journal:  Mod Pathol       Date:  1991-05       Impact factor: 7.842

Review 7.  Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.

Authors:  C Eng; L M Mulligan
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

8.  Inherited medullary microcarcinoma of the thyroid: a study of 11 cases.

Authors:  J E Krueger; A Maitra; J Albores-Saavedra
Journal:  Am J Surg Pathol       Date:  2000-06       Impact factor: 6.394

9.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

10.  Immunostains for collagen type IV discriminate between C-cell hyperplasia and microscopic medullary carcinoma in multiple endocrine neoplasia, type 2a.

Authors:  M B McDermott; P E Swanson; M R Wick
Journal:  Hum Pathol       Date:  1995-12       Impact factor: 3.466

View more
  2 in total

1.  Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations.

Authors:  Adi Gazdar; Linda Robinson; Dwight Oliver; Chao Xing; William D Travis; Junichi Soh; Shinichi Toyooka; Lori Watumull; Yang Xie; Kemp Kernstine; Joan H Schiller
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

2.  Medullary thyroid cancer in a 9-week-old infant with familial MEN 2B: Implications for timing of prophylactic thyroidectomy.

Authors:  Roopa Kanakatti Shankar; Michael J Rutter; Steven D Chernausek; Paul J Samuels; Jun Qin Mo; Meilan M Rutter
Journal:  Int J Pediatr Endocrinol       Date:  2012-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.